A Brief History of Shigella.

EcoSal Plus
Keith A LampelA T Maurelli

Abstract

The history of Shigella, the causative agent of bacillary dysentery, is a long and fascinating one. This brief historical account starts with descriptions of the disease and its impact on human health from ancient time to the present. Our story of the bacterium starts just before the identification of the dysentery bacillus by Kiyoshi Shiga in 1898 and follows the scientific discoveries and principal scientists who contributed to the elucidation of Shigella pathogenesis in the first 100 years. Over the past century, Shigella has proved to be an outstanding model of an invasive bacterial pathogen and has served as a paradigm for the study of other bacterial pathogens. In addition to invasion of epithelial cells, some of those shared virulence traits include toxin production, multiple-antibiotic resistance, virulence genes encoded on plasmids and bacteriophages, global regulation of virulence genes, pathogenicity islands, intracellular motility, remodeling of host cytoskeleton, inflammation/polymorphonuclear leukocyte signaling, apoptosis induction/inhibition, and "black holes" and antivirulence genes. While there is still much to learn from studying Shigella pathogenesis, what we have learned so far has also contributed greatly ...Continue Reading

References

Jul 1, 1977·Sexually Transmitted Diseases·M BaderH Anderson
May 1, 1978·The Journal of Infectious Diseases·S B Formal, R B Hornick
Oct 1, 1977·Infection and Immunity·S M Payne, R A Finkelstein
Dec 1, 1976·Bacteriological Reviews·D H Duckworth
Jul 9, 1992·Nature·A ZychlinskyP J Sansonetti
Mar 15, 1991·American Journal of Epidemiology·L A LeeP M Griffin
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M L BernardiniP J Sansonetti
Jun 1, 1989·The Journal of Infectious Diseases·H L DuPontS B Formal
Jul 1, 1985·Infection and Immunity·A T MaurelliP J Sansonetti
Jul 1, 1988·Reviews of Infectious Diseases·S Falkow
Apr 1, 1985·Infection and Immunity·E V OaksS B Formal
Nov 28, 1974·The New England Journal of Medicine·S Gupte
Jul 1, 1972·The Journal of Infectious Diseases·G T KeuschH Sprinz
May 1, 1972·The Journal of Clinical Investigation·G T KeuschJ McIver
Aug 1, 1968·Japanese Journal of Medical Science & Biology·H OgawaR Nakaya
May 1, 1969·Journal of Bacteriology·D J BrennerS Falkow
Sep 1, 1970·The Journal of Infectious Diseases·L J MataM L Mejicanos
Sep 1, 1970·The Journal of Infectious Diseases·E J GangarosaL B Reller
Dec 1, 1967·Scientific American·T Watanabe
Oct 1, 1981·Infection and Immunity·P J SansonettiS B Formal
Mar 1, 1982·Infection and Immunity·P J SansonettiS B Formal
Jan 1, 1984·Infection and Immunity·A T MaurelliR Curtiss
Jun 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K C HyamsE C Oldfield
May 1, 1994·The Journal of Infectious Diseases·A A RiesS P Wahlquist
Apr 1, 1993·Epidemiology and Infection·F M KennedyT Cheasty
Jul 1, 1996·Infection and Immunity·N MantisP Sansonetti
Nov 29, 1996·Cell·E A Groisman, H Ochman

❮ Previous
Next ❯

Citations

Sep 16, 2020·Archives of Microbiology·Ahtesham Ahmad Shad, Wajahat Ahmed Shad
Dec 12, 2018·Microbiology Resource Announcements·Jayanthi GangiredlaAmit Mukherjee
Dec 10, 2020·Microorganisms·Waad BajunaidFrançois-Xavier Campbell-Valois
Dec 2, 2020·Comparative Immunology, Microbiology and Infectious Diseases·A TardónE Jiménez-Trigos
Oct 30, 2020·International Journal of Hygiene and Environmental Health·Kathy H NguyenElizabeth T Rogawski McQuade
Sep 16, 2021·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Fatima Bachir HalimehMonzer Hamze

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Kazumine Kibari
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
A F TrofaM Yoshikawa
The Journal of Infectious Diseases
P S Brachman
© 2022 Meta ULC. All rights reserved